Reply to Letter: “Impact of Hypertension on the Prognosis of COVID-19 Disease and Uncertainties that Need to be Clarified”

Abstract

Get full access to this article

View all access options for this article.

References

Sanlialp

. Impact of hypertension on the prognosis of COVID-19 disease and uncertainties that need to be clarified. Angiology 2021 July 14: 00033197211032784. doi:10.1177/00033197211032784. Online ahead of print.

Saylik

Akbulut

Kaya

. Can C-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension? Angiology 2021; 72: 947–952.

Rodilla

Saura

Jiménez

, et al. Association of hypertension with all-cause mortality among hospitalized patients with COVID-19. J Clin Med 2020; 9: 3136.

Selçuk

Çınar

Keskin

, et al.

Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

Clin Exp Hypertens 2020; 42: 738–742.

Zuin

Rigatelli

Zuliani

, et al. Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis. J Infect 2020; 81: e84–e86.

Ran

Song

Zhuang

, et al. Blood pressure control and adverse outcomes of COVID-19 infection in patients with concomitant hypertension in Wuhan, China. Hypertens Res 2020; 43: 1267–1276.

Chen

Yang

Gao

, et al. Influence of blood pressure control and application of renin-angiotensin-aldosterone system inhibitors on the outcomes in COVID-19 patients with hypertension. J Clin Hypertens 2020; 22: 1974–1983.